Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company developing desensitization treatments to protect people with food allergies from the life-threatening consequences of accidental exposures to their allergens. We are currently conducting a Phase 3 study of our lead product, AR101 for the treatment of peanut allergy.
Type
Public
HQ
Brisbane, US
Founded
2011
Size (employees)
62 (est)+15%
Aimmune Therapeutics was founded in 2011 and is headquartered in Brisbane, US

Aimmune Therapeutics Office Locations

Aimmune Therapeutics has an office in Brisbane
Brisbane, US (HQ)
300 8000 Marina Blvd

Aimmune Therapeutics Metrics

Aimmune Therapeutics Market Value History

Aimmune Therapeutics Online Presence

Aimmune Therapeutics Company Life

You may also be interested in